Similarly, RPP40 was also regarded as one of the promoting factors for the chemoresistance of acute myeloid leukemia (15), and the member of a prognostic signature includes seven mRNAs and could accurately predict the recurrence risks of early-stage triple-negative breast cancer (16). The gene discussed is RPP40; the disease is triple-negative breast carcinoma.